Clinical effectiveness of hemoglobin spray (Granulox ® ) as adjunctive therapy in the treatment of chronic diabetic foot ulcers
Diabetic Foot & Ankle · 2016-01 · 7 (1) · 33101
DOI: 10.3402/dfa.v7.33101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Foot & Ankle, online erschienen am 07.11.2016. Verfasst von Sharon D Hunt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wellway Medical Group Northumberland, Berwick Upon Tweed, United Kingdom; Sharon.hunt10@nhs.net. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wellway Medical Group Northumberland, Berwick Upon Tweed, United Kingdom; Sharon.hunt10@nhs.net.
- Pracipio Ltd, London, United Kingdom.
Zitieren
APA
Hunt, S. D., & Elg, F. (2016). Clinical effectiveness of hemoglobin spray (Granulox ® ) as adjunctive therapy in the treatment of chronic diabetic foot ulcers. Diabetic Foot & Ankle, 7(1), 33101. https://doi.org/10.3402/dfa.v7.33101
Vancouver
Hunt SD, Elg F. Clinical effectiveness of hemoglobin spray (Granulox ® ) as adjunctive therapy in the treatment of chronic diabetic foot ulcers. Diabetic Foot & Ankle. 2016;7(1):33101. doi:10.3402/dfa.v7.33101
BibTeX
@article{Hunt2016,
author = {Hunt, Sharon D and Elg, Fredrik},
title = {Clinical effectiveness of hemoglobin spray (Granulox ® ) as adjunctive therapy in the treatment of chronic diabetic foot ulcers},
journal = {Diabetic Foot & Ankle},
year = {2016},
volume = {7},
number = {1},
pages = {33101},
doi = {10.3402/dfa.v7.33101}
}
EUVIMED